Assessment of In Vivo and In Vitro Genotoxicity of Glibenclamide in Eukaryotic Cells

Glibenclamide is an oral hypoglycemic drug commonly prescribed for the treatment of type 2 diabetes mellitus, whose anti-tumor activity has been recently described in several human cancer cells. The mutagenic potential of such an antidiabetic drug and its recombinogenic activity in eukaryotic cells...

Descripción completa

Detalles Bibliográficos
Autores principales: de Sant’Anna, Juliane Rocha, Franco, Claudinéia Conationi da Silva, Mathias, Paulo Cezar de Freitas, de Castro-Prado, Marialba Avezum Alves
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4372363/
https://www.ncbi.nlm.nih.gov/pubmed/25803314
http://dx.doi.org/10.1371/journal.pone.0120675

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4372363/
https://www.ncbi.nlm.nih.gov/pubmed/25803314
http://dx.doi.org/10.1371/journal.pone.0120675

Ejemplares similares